In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
about
Antimicrobial Combinations against Pan-Resistant Acinetobacter baumannii Isolates with Different Resistance MechanismsThe two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria.A Review of Novel Combinations of Colistin and Lipopeptide or Glycopeptide Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii.Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care UnitOptimizing Polymyxin Combinations Against Resistant Gram-Negative BacteriaAnti-microbial, anti-biofilm activities and cell selectivity of the NRC-16 peptide derived from witch flounder, Glyptocephalus cynoglossus.In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates.Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteria.Synergistic combinations of polymyxins.Treatment option for sepsis in children in the era of antibiotic resistance.Recent advances and perspectives in the design and development of polymyxins.Clinical Pharmacokinetics and Pharmacodynamics of Colistin.Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii.Antibiotic combinations for controlling colistin-resistant Enterobacter cloacae.In Vitro and In Vivo Efficacy of an LpxC Inhibitor, CHIR-090, Alone or Combined with Colistin against Pseudomonas aeruginosa Biofilm.Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model.In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.Postantibiotic effect of colistin alone and combined with vancomycin or meropenem against Acinetobacter spp. with well defined resistance mechanisms.Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria.Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics.Capillary electrophoresis for fast detection of heterogeneous population in colistin-resistant Gram-negative bacteria.Sulbactam enhances the activity of sitafloxacin against extensively-drug resistant
P2860
Q28550908-36046152-B0FF-402C-B6D1-F2E884A4F518Q31140261-37AD9F91-73CA-401D-83A7-2CC9157C2032Q34726120-14ECA59B-CE00-487C-9902-844C019B9BB4Q34922363-220153BC-EDB8-4C9D-81F5-F4DEE7C3C220Q35794409-F1C42A7E-3C6F-4234-A446-F240629D859BQ36363261-6ED09F4A-3D20-4FF0-B837-909B06D20068Q37040038-64B9715D-397C-4E7E-B310-AD2ACC742F11Q37358693-01FC5504-FEA7-4F56-A4C3-9CACB1178C7BQ37358737-B7F4C043-DA9C-4B91-B370-C8126337671AQ37544860-9CDEFDEC-934E-442B-AD3F-8322F534746FQ37586960-ACB684D1-104E-4428-A8E5-EBFC8DF04926Q38246118-3ED3A178-A4AC-4136-B15D-770F0D2FE910Q39190865-DC4A96AD-F119-4EDA-999E-49ACD1796196Q39333751-2224D199-A0CE-4696-8E9B-D5E4AD08925EQ39503267-D7682D6B-51F6-4280-8360-AC9E419390DEQ39629148-42F88696-3CBD-4A29-977B-40AD6E282BE3Q40230660-076C3673-1AE6-4FB3-BCDF-505A3AE6D695Q40802708-F9748FC0-6472-4B97-A5B6-E7D228F0A90AQ40936660-9509170E-04BE-470D-B71B-1F6835AD6929Q41026343-BCC77B5E-1ABF-48B2-9160-DAB557915882Q44345895-52B960CE-32C4-47C5-91F5-6D8E17CCEA9DQ49206197-F3ACF93C-F859-42B0-940C-1099F47845E2Q53836580-C30B142B-6E15-4749-90D8-7E63966E9DE6Q58733403-29605C47-4D76-4D36-8E98-C3886342FE27
P2860
In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
In vitro synergy of colistin c ...... lebsiella pneumoniae isolates.
@ast
In vitro synergy of colistin c ...... lebsiella pneumoniae isolates.
@en
type
label
In vitro synergy of colistin c ...... lebsiella pneumoniae isolates.
@ast
In vitro synergy of colistin c ...... lebsiella pneumoniae isolates.
@en
prefLabel
In vitro synergy of colistin c ...... lebsiella pneumoniae isolates.
@ast
In vitro synergy of colistin c ...... lebsiella pneumoniae isolates.
@en
P2093
P2860
P356
P1476
In vitro synergy of colistin c ...... lebsiella pneumoniae isolates.
@en
P2093
Céline Vidaillac
Lothaire Benichou
Raphaël E Duval
P2860
P304
P356
10.1128/AAC.05996-11
P407
P577
2012-07-02T00:00:00Z